Impact of endobronchial valves on patient reported outcomes in severe emphysema

Conclusion: Data from the LIBERATE trial demonstrates that the Zephyr Valve significantly improves multidimensional measures of dyspnea and quality of life.

Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Dransfield, M., Bhatt, S., Slebos, D.-J., Klooster, K., Sciurba, F., Shah, P., Garner, J., Radhakrishnan, S., Shargill, N., Marchetti, N., Criner, G. Tags: Interventional pulmonology Source Type: research